Volume 29, Number 9—September 2023
Dispatch
Infection-Induced SARS-CoV-2 Seroprevalence among Blood Donors, Japan, 2022
Figure 1

Figure 1. Reported COVID-19 cases among the general population and seroprevalence of SARS-CoV-2 among blood donors, Japan. A) Number of reported COVID-19 cases by date of report, 2020–2022. Orange line indicates cumulative number of reported cases per 1 million persons. Green shading indicates survey period. B) Weighted seroprevalence stratified of SARS-CoV-2 among blood donors from November 6–13, 2022, by age group and sex. Error bars represent 95% CIs.
1These senior authors contributed equally to this article.
Page created: July 17, 2023
Page updated: August 20, 2023
Page reviewed: August 20, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.